CN Stock MarketDetailed Quotes
301089 Tuoxin Pharmaceutical Group
- 28.36
- -0.34-1.18%
Trading Jan 9 13:24 CST
3.59BMarket Cap-49.32P/E (TTM)
28.82High27.70Low21.00KlotVolume28.40Open28.70Pre Close59.40MTurnover2.31%Turnover Ratio14.76P/E (Static)126.54MShares55.4352wk High2.29P/B2.58BFloat Cap25.9552wk Low34.44Limit Up90.98MShs Float229.25Historical High22.96Limit Down3.90%Amplitude24.35Historical Low0.25Dividend TTM28.29Avg Price11.71KlotAsk0.88%Div YieldTTM100Lot Size8.41KlotBid
Tuoxin Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -56.34%325.75M | -66.70%218.76M | -80.34%108.32M | 6.47%835.51M | 76.42%746.13M | 166.36%656.98M | 325.33%551.01M | 56.17%784.72M | 8.88%422.92M | -13.16%246.65M |
| Operating revenue | -56.34%325.75M | -66.70%218.76M | -80.34%108.32M | 6.47%835.51M | 76.42%746.13M | 166.36%656.98M | 325.33%551.01M | 56.17%784.72M | 8.88%422.92M | -13.16%246.65M |
| Other operating revenue | ---- | --0 | ---- | -48.96%3.53M | ---- | -14.88%4.57M | ---- | 211.47%6.91M | ---- | 157.78%5.37M |
| Total operating cost | -4.64%349.46M | -9.89%230.77M | -23.19%111.6M | 10.64%517.16M | 16.54%366.45M | 26.10%256.09M | 46.58%145.29M | 9.98%467.41M | 0.95%314.43M | -7.21%203.09M |
| Operating cost | 7.24%242.08M | 2.23%165.05M | -15.92%79.99M | 12.45%351.95M | -1.45%225.74M | 9.51%161.45M | 31.34%95.13M | 0.33%313M | -3.10%229.07M | -12.75%147.42M |
| Operating tax surcharges | -53.97%5.19M | -69.36%2.98M | -83.16%1.28M | 10.65%13.02M | 106.30%11.27M | 159.76%9.74M | 390.38%7.58M | 73.40%11.77M | 13.93%5.47M | 7.11%3.75M |
| Operating expense | 5.99%9.52M | 2.73%6.03M | -19.39%2.1M | 9.64%9.83M | 67.92%8.99M | 63.34%5.87M | 32.63%2.61M | 30.63%8.96M | 6.27%5.35M | 14.00%3.59M |
| Administration expense | -25.43%65.79M | -27.50%42.92M | -40.31%20.72M | -10.51%94.47M | 50.28%88.22M | 58.33%59.21M | 90.76%34.72M | 51.13%105.57M | 34.31%58.71M | 34.67%37.4M |
| Financial expense | 25.17%-2.03M | -13.55%-2.39M | -253.08%-728.9K | -15.56%-3.36M | 14.74%-2.72M | 13.20%-2.1M | 59.42%-206.44K | -134.06%-2.91M | -141.62%-3.19M | -144.23%-2.42M |
| -Interest expense (Financial expense) | ---- | ---- | -99.78%620.52 | -90.04%337.07K | -88.10%285.06K | -86.60%238.68K | -68.10%285.06K | -62.92%3.38M | -68.82%2.4M | -65.81%1.78M |
| -Interest Income (Financial expense) | -134.54%-2.26M | -3.56%-1.82M | 49.53%-487.28K | 34.53%-3.29M | 72.56%-965.43K | 36.21%-1.76M | 41.75%-965.43K | -109.39%-5.02M | -244.65%-3.52M | -292.88%-2.75M |
| Research and development | -17.26%28.91M | -26.28%16.17M | 50.92%8.25M | 65.22%51.25M | 83.58%34.94M | 64.22%21.93M | -0.49%5.46M | 47.91%31.02M | 36.90%19.03M | 33.65%13.36M |
| Credit Impairment Loss | 145.00%3.16M | 130.07%2.42M | 127.82%2.39M | -188.41%-4.49M | -239.36%-7.01M | -315.14%-8.04M | -966.55%-8.58M | 322.78%5.07M | 803.52%5.03M | 389.28%3.74M |
| Asset Impairment Loss | ---- | ---- | ---- | -12.00%-10.77M | -1,249.42%-4.15M | -1,107.76%-3.64M | ---- | -820.89%-9.61M | 284.90%361.05K | 120.44%361.05K |
| Other net revenue | 647.16%16.56M | 432.69%10.86M | 227.33%5.76M | -72.15%3.34M | -89.06%2.22M | -124.31%-3.27M | -189.04%-4.52M | 587.24%11.98M | 940.58%20.25M | 1,519.74%13.43M |
| Fair value change income | -193.22%-463.66K | -156.21%-544.78K | -345.84%-705K | 245.84%546.87K | -110.00%-158.13K | -11.75%969.16K | ---158.13K | -74.49%158.13K | --1.58M | --1.1M |
| Invest income | -52.88%2.96M | -44.38%1.95M | 5.33%1.45M | 16.97%6.57M | 78.07%6.29M | 52.45%3.51M | 8.74%1.38M | 60,036.24%5.62M | 42,673.26%3.53M | 32,793.54%2.3M |
| -Including: Investment income associates | ---- | ---- | ---- | -339.15%-115.51 | ---- | ---- | ---- | -99.48%48.3 | -100.09%-7.73 | -100.11%-7.73 |
| Asset deal income | ---- | ---- | ---4.91K | ---- | ---- | ---- | ---- | --28.07K | ---- | ---- |
| Other revenue | 50.38%10.9M | 78.71%7.03M | -7.12%2.63M | 7.03%11.47M | -25.64%7.25M | -33.60%3.94M | 0.36%2.83M | 141.71%10.72M | 242.19%9.75M | 181.53%5.93M |
| Operating profit | -101.87%-7.15M | -100.29%-1.15M | -99.38%2.48M | -2.31%321.68M | 196.64%381.9M | 597.74%397.62M | 1,029.85%401.19M | 315.54%329.29M | 63.19%128.74M | -11.26%56.99M |
| Add:Non operating Income | 10,314.26%148.19K | 19,562.18%83.16K | 49,829.20%29.96K | -84.31%1.42K | --1.42K | --422.96 | --60 | 235.80%9.07K | ---- | ---- |
| Less:Non operating expense | 70.72%3.9M | -86.85%267.75K | -96.76%54.63K | 27.81%5.15M | 91.79%2.28M | 135.91%2.04M | 298.61%1.69M | 234.31%4.03M | 314.23%1.19M | 209.05%863.05K |
| Total profit | -102.87%-10.9M | -100.34%-1.33M | -99.39%2.45M | -2.69%316.53M | 197.62%379.62M | 604.85%395.58M | 1,038.67%399.5M | 316.79%325.27M | 62.26%127.55M | -12.22%56.12M |
| Less:Income tax cost | -112.41%-8.24M | -99.48%446.07K | -99.60%383.82K | 89.65%73.46M | 267.70%66.42M | 4,063.55%86.05M | 1,332.44%95.2M | 214.14%38.73M | 42.01%18.06M | -80.49%2.07M |
| Net profit | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.17%243.07M | 186.06%313.19M | 472.61%309.53M | 970.02%304.31M | 336.05%286.54M | 66.17%109.48M | 1.34%54.06M |
| Net profit from continuing operation | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.17%243.07M | 186.06%313.19M | 472.61%309.53M | 970.02%304.31M | 336.05%286.54M | 66.17%109.48M | 1.34%54.06M |
| Net profit of parent company owners | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.17%243.07M | 186.06%313.19M | 472.61%309.53M | 970.02%304.31M | 336.05%286.54M | 66.17%109.48M | 1.34%54.06M |
| Earning per share | ||||||||||
| Basic earning per share | -100.80%-0.02 | -100.41%-0.01 | -99.17%0.02 | -14.98%1.93 | 186.21%2.49 | 472.09%2.46 | 952.17%2.42 | 243.94%2.27 | 24.29%0.87 | -23.21%0.43 |
| Diluted earning per share | -100.80%-0.02 | -100.41%-0.01 | -99.17%0.02 | -14.98%1.93 | 186.21%2.49 | 472.09%2.46 | 952.17%2.42 | 243.94%2.27 | 24.29%0.87 | -23.21%0.43 |
| Other composite income | -26.56%-2.13M | 32.79%-1.68M | -290.64%-332.05K | -290.64%-332.05K | ||||||
| Other composite income of parent company owners | ---- | ---- | ---- | -26.56%-2.13M | ---- | ---- | ---- | 32.79%-1.68M | -290.64%-332.05K | -290.64%-332.05K |
| Total composite income | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.41%240.95M | 186.93%313.19M | 476.15%309.53M | 970.02%304.31M | 350.64%284.86M | 65.23%109.15M | 0.39%53.72M |
| Total composite income of parent company owners | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.41%240.95M | 186.93%313.19M | 476.15%309.53M | 970.02%304.31M | 350.64%284.86M | 65.23%109.15M | 0.39%53.72M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
